Annual EBIT
-$238.00 M
-$76.16 M-47.06%
December 31, 2021
Summary
- As of February 10, 2025, TPTX annual earnings before interest & taxes is -$238.00 million, with the most recent change of -$76.16 million (-47.06%) on December 31, 2021.
- During the last 3 years, TPTX annual EBIT has fallen by -$212.36 million (-828.24%).
Performance
TPTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$124.36 M
-$49.43 M-65.96%
June 30, 2022
Summary
- As of February 10, 2025, TPTX quarterly earnings before interest & taxes is -$124.36 million, with the most recent change of -$49.43 million (-65.96%) on June 30, 2022.
- Over the past year, TPTX quarterly EBIT has dropped by -$67.71 million (-119.50%).
Performance
TPTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$344.59 M
-$67.71 M-24.45%
June 30, 2022
Summary
- As of February 10, 2025, TPTX TTM earnings before interest & taxes is -$344.59 million, with the most recent change of -$67.71 million (-24.45%) on June 30, 2022.
- Over the past year, TPTX TTM EBIT has dropped by -$185.41 million (-116.47%).
Performance
TPTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TPTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.1% | -119.5% | -116.5% |
| 3 y3 years | -828.2% | -573.9% | -343.4% |
| 5 y5 years | -1322.7% | -2458.9% | -343.4% |
TPTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +66.0% | at low | +44.8% | at low |
| 5 y | 5-year | +206.2% | at low | +570.8% | at low | +343.4% | at low |
| alltime | all time | +1322.7% | at low | +2458.9% | at low | +6990.4% | at low |
Turning Point Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$124.36 M(+66.0%) | -$344.59 M(+24.5%) |
| Mar 2022 | - | -$74.94 M(-4.7%) | -$276.89 M(+16.3%) |
| Dec 2021 | -$238.00 M(+47.1%) | -$78.64 M(+18.0%) | -$238.00 M(+14.8%) |
| Sep 2021 | - | -$66.65 M(+17.6%) | -$207.30 M(+30.2%) |
| Jun 2021 | - | -$56.66 M(+57.2%) | -$159.18 M(+17.7%) |
| Mar 2021 | - | -$36.05 M(-24.8%) | -$135.26 M(-16.4%) |
| Dec 2020 | -$161.84 M | -$47.94 M(+158.6%) | -$161.84 M(+18.2%) |
| Sep 2020 | - | -$18.54 M(-43.4%) | -$136.96 M(-2.6%) |
| Jun 2020 | - | -$32.73 M(-47.7%) | -$140.56 M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$62.63 M(+171.5%) | -$126.28 M(+62.5%) |
| Dec 2019 | -$77.72 M(+203.1%) | -$23.07 M(+4.2%) | -$77.72 M(+21.2%) |
| Sep 2019 | - | -$22.14 M(+20.0%) | -$64.14 M(+33.3%) |
| Jun 2019 | - | -$18.45 M(+31.2%) | -$48.13 M(+38.1%) |
| Mar 2019 | - | -$14.06 M(+48.4%) | -$34.85 M(+35.9%) |
| Dec 2018 | -$25.64 M(+53.3%) | -$9.48 M(+54.7%) | -$25.64 M(+58.7%) |
| Sep 2018 | - | -$6.13 M(+18.5%) | -$16.16 M(+61.1%) |
| Jun 2018 | - | -$5.17 M(+6.4%) | -$10.03 M(+106.4%) |
| Mar 2018 | - | -$4.86 M | -$4.86 M |
| Dec 2017 | -$16.73 M | - | - |
FAQ
- What is Turning Point Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Turning Point Therapeutics?
- What is Turning Point Therapeutics annual EBIT year-on-year change?
- What is Turning Point Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Turning Point Therapeutics?
- What is Turning Point Therapeutics quarterly EBIT year-on-year change?
- What is Turning Point Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Turning Point Therapeutics?
- What is Turning Point Therapeutics TTM EBIT year-on-year change?
What is Turning Point Therapeutics annual earnings before interest & taxes?
The current annual EBIT of TPTX is -$238.00 M
What is the all time high annual EBIT for Turning Point Therapeutics?
Turning Point Therapeutics all-time high annual earnings before interest & taxes is -$16.73 M
What is Turning Point Therapeutics annual EBIT year-on-year change?
Over the past year, TPTX annual earnings before interest & taxes has changed by -$76.16 M (-47.06%)
What is Turning Point Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of TPTX is -$124.36 M
What is the all time high quarterly EBIT for Turning Point Therapeutics?
Turning Point Therapeutics all-time high quarterly earnings before interest & taxes is -$4.86 M
What is Turning Point Therapeutics quarterly EBIT year-on-year change?
Over the past year, TPTX quarterly earnings before interest & taxes has changed by -$67.71 M (-119.50%)
What is Turning Point Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of TPTX is -$344.59 M
What is the all time high TTM EBIT for Turning Point Therapeutics?
Turning Point Therapeutics all-time high TTM earnings before interest & taxes is -$4.86 M
What is Turning Point Therapeutics TTM EBIT year-on-year change?
Over the past year, TPTX TTM earnings before interest & taxes has changed by -$185.41 M (-116.47%)